Bacteriophage-derived ectolysin: a promising antimicrobial against fluoroquinolone-resistant MRSA.
The therapeutic potential of P128 is demonstrated for the management of drug-resistant MRSA keratitis and its combination with antimicrobial peptides may expand the antimicrobial armamentarium against biofilm-associated infections.